Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Feedback-Driven Mechanisms Between Phosphorylated Caveolin-1 and Contractile Actin Assemblies Instruct Persistent Cell Migration. | Front Cell Dev Biol | 2021 | 33928090 | PubTator, text mining | PubMed |
| Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis. | Front Oncol | 2021 | 33928032 | PubTator, text mining | PubMed |
| What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype. | Int J Mol Sci | 2021 | 33922532 | PubTator, text mining | PubMed |
| A Comparative Analysis of Erythropoietin and Carbamoylated Erythropoietin Proteome Profiles. | Life (Basel) | 2021 | 33921564 | PubTator, text mining | PubMed |
| Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. | Int J Mol Sci | 2021 | 33921242 | PubTator, text mining | PubMed |
| Physiological and Transcriptomic Analysis Provide Insight into Low Temperature Enhancing Hypericin Biosynthesis in Hypericum perforatum. | Molecules | 2021 | 33921038 | PubTator, text mining | PubMed |
| Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis. | Cancers (Basel) | 2021 | 33919917 | PubTator, text mining | PubMed |
| Inhibiting FAK-Paxillin Interaction Reduces Migration and Invadopodia-Mediated Matrix Degradation in Metastatic Melanoma Cells. | Cancers (Basel) | 2021 | 33919725 | PubTator, text mining | PubMed |
| Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance. | Cells | 2021 | 33918883 | PubTator, text mining | PubMed |
| Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update. | J Clin Med | 2021 | 33917535 | PubTator, text mining | PubMed |
| The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking. | Cancers (Basel) | 2021 | 33917287 | PubTator, text mining | PubMed |
| N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | Int J Mol Sci | 2021 | 33916271 | PubTator, text mining | PubMed |
| Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment. | Life Sci | 2021 | 33915132 | PubTator, text mining | PubMed |
| Prognostic value of SH3PXD2B (Tks4) in human hepatocellular carcinoma: a combined multi-omics and experimental study. | BMC Med Genomics | 2021 | 33906640 | PubTator, text mining | PubMed |
| Ubiquitous membrane-bound DNase activity in podosomes and invadopodia. | J Cell Biol | 2021 | 33904858 | PubTator, text mining | PubMed |
| Prednisolone Alters Endometrial Decidual Cells and Affects Decidual-Trophoblast Interactions. | Front Cell Dev Biol | 2021 | 33898438 | PubTator, text mining | PubMed |
| The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation. | Theranostics | 2021 | 33897885 | PubTator, text mining | PubMed |
| Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy. | Mol Psychiatry | 2021 | 33888873 | PubTator, text mining | PubMed |
| Palladium Nanoparticle-Induced Oxidative Stress, Endoplasmic Reticulum Stress, Apoptosis, and Immunomodulation Enhance the Biogenesis and Release of Exosome in Human Leukemia Monocytic Cells (THP-1). | Int J Nanomedicine | 2021 | 33883895 | PubTator, text mining | PubMed |
| Key proteins of invadopodia are overexpressed in oral squamous cell carcinoma suggesting an important role of MT1-MMP in the tumoral progression. | Diagn Pathol | 2021 | 33879222 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=56